HSD17B13 and metabolic dysfunction-associated steatotic liver disease: Immunohistochemical analysis revealed that hepatic HSD17B13 expression in the livers of murine models with NAFLD (Supplementary Figure S1A,B) was markedly increased compared to in normal liver tissue samples (Figure 1D).